Health Canada
www.hc-sc.gc.ca
Common menu bar links
Institutional links
About Health Canada
ARCHIVED - Access to Information Requests Completed - December 2011
This content was archived on June 24 2013.
Archived Content
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)
If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.
Acronyms and Descriptions
- AER
- Adverse Reaction Report (Adverse Event)
- DIN
- Drug Identification Number
- MECS
- Ministerial Executive Correspondence System
- NPN
- Natural Product Number
- SAP
- Special Access Program
Completed Requests
| Request # | Summary of Requests | Status of Completed Request | Number of Pages Disclosed |
|---|---|---|---|
| A-2009-00172 | Information regarding the product INSPRA (Eplerenone) by Pfizer Canada Inc. | Disclosed in part | 888 |
| A-2009-00987 | Documents relative to the outbreak of listeriosis at a meat processing plant in August 2008, two investigations were undertaken and reports published by:
|
Disclosed in part | 1,004 |
| A-2010-00055 | Licensing information on the non-surgical spinal decompression system known as DRX 9000. | Disclosed in part | 32 |
| A-2010-01190 | All documents relating to the commitment from 'infoway to report annually on lobbying activities' as described within the Health Canada Audit and Accountability Bureau's Final Audit Report Audit of Transfer Payments to Canada Health Infoway Inc. May 2009. | All disclosed | 42 |
| A-2010-01191 | All 'assessment of funds' invested by Health Canada InfowayInc as described within the Health Canada Audit and Accountability Bureau's "Final Audit Report Audit of Transfer Payments to Canada Health Infoway Inc. May 2009". | Disclosed in part | 68 |
| A-2010-01192 | All funding agreements between Health Canada and Canada Health InfowayInc as described within the Health Canada Audit and Accountability Bureau's "Final Audit of Transfer Payments to Canada Health InfowayInc May 2009" | All disclosed | 127 |
| A-2010-01416 | All Standard Operating Procedures and/or internal procedures/processes currently in effect for the processing, handling and management of Electronic Common Technical Document (eCTD) submissions and non-eCTD electronic submissions by the Submission and Information Policy Division. | Disclosed in part | 371 |
| A-2010-01420 | All documents that allowed the registration of the product Mirapex by BoehringerIngelheim Canada LTD/LTEE. | Disclosed in part | 72 |
| A-2010-01585 | Information regarding the product Best Omega-3 Lycopene, NPN 80004065 by Nutragenius Inc. | Disclosed in part | 70 |
| A-2010-01601 | A copy of the Canadian Risk Management Planand the Reviewer's Report, and also the details of theAtemra Patient Registry Program regarding the product ACTEMRA, DINs 02350092, 02350106 and 02350014. | Disclosed in part | 1,078 |
| A-2011-00066 | All relevant information on the company named White Ophthalmic Supply Co. Ltd. | Disclosed in part | 944 |
| A-2011-00110 | Information regarding the product DECONGESTANT NOSE DROPS 0.1%, DIN 00851256. | Disclosed in part | 10 |
| A-2011-00111 | Information regarding the product DIPHENHYDRAMINE HCL CHILDREN'S LIQUID, DIN 02171279. | Disclosed in part | 9 |
| A-2011-00116 | Information regarding the productLOTION ÉCRAN SOLAIRE SPF 30 EX, DIN 02237179. | Disclosed in part | 22 |
| A-2011-00120 | Information regarding the product DECONGESTANT NASAL MIST LONG LASTING, DIN 02213907. | Disclosed in part | 17 |
| A-2011-00121 | Information regarding the product DIPHENHYDRAMINE HYDROCHLORIDE ELIXIR U.S.P., DIN 02164574. | Disclosed in part | 21 |
| A-2011-00124 | Information regarding the product MEDICAMENT POUR LES SINUS EXTRA-FORT CAPLET, DIN 00899771. | Disclosed in part | 8 |
| A-2011-00176 | AERs. Report numbers: 000173435, 000173446, 000173551, 000173558, 000173561, 000173657, 000173801, 000174195, 000174588 and 000175246. | Disclosed in part | 65 |
| A-2011-00178 | AERs. Report numbers: 000178603, 000178607, 000178863, 000179474, 000180302, 000180304, 000180570, 000180581, 000180829 and 000182123. | Disclosed in part | 27 |
| A-2011-00179 | AERs. Report numbers: 000208866, 000209139, 000209542, 000210366, 000210367, 000211670, 000211853, 000212516, 000212702 and 000213117. | Disclosed in part | 35 |
| A-2011-00183 | AERs. Report numbers: 000219414, 000219573, 000221175, 000221226, 000221631, 000226020, 000226248, 000120550, 000133652 and 000173551. | All disclosed | 25 |
| A-2011-00191 | AERs. Report numbers: 000197201, 000195791, 000195943, 000196138, 000196585, 000196617, 000196633, 000196638, 000196699 and 000196701. | Disclosed in part | 46 |
| A-2011-00192 | AERs. Report numbers: 000191448, 000191508, 000191763, 000191958, 000191988, 000192530, 000192532, 000192662, 000192665 and 000193251. | Disclosed in part | 41 |
| A-2011-00234 | Information regarding the product Advil Cold and Sinus, DIN 02036312 by Pfizer Consumer Healthcare, a division of Pfizer Canada Inc. | Disclosed in part | 609 |
| A-2011-00301 | All correspondence between Ministry Officials within Health Canada and/or Federal and Provincial Counterparts related to the Common Purchasing Alliance for Drugs/Pharmaceuticals and Medical Supplies/Devices. (May 1, 2010 to Jun 6, 2011). | Disclosed in part | 31 |
| A-2011-00318 | AERs for the product Motrin. Report numbers: 000013354, 000023379, 000027308, 000036231, 000069832, 000122574, 000123423, 000130103, 000134878, 000156916, 000158543, 000160273, 000160994, 000168105, 000171436, 000171496, 000175796, 000176912, 000179041, 000179371, 000180421, 000182499, 000183139, 000186467, 000186476, 000191081, 000205772, 000223988, 000224204, 000225190, 000303591, 000303592, 000303654, 000305909, 000315352, 000315555, 000316009, 000328270, 000329282, 000329284, 000329289, 000329290, 000330385, 000332955, 000343404, 000343406, 000343483, 000343484, 000343685, 000343686, 000343743, 000343745, 000343747, 000343750, 000343756, 000343757, 000343758, 000343923, 000343927, 000344545, 000344908, 000344927, 000345370, 000345642 and 000351621. | Disclosed in part | 508 |
| A-2011-00324 | All documents in MECS for the following files: 10-103115-560), 10-105669-177, 10-105155-540, 10-104292-728, 10-106362-967, 10-107144-328) and 10-106449-78. | Disclosed in part | 240 |
| A-2011-00377 | Information regarding the product Yaz (drospirenone/ethinyl estradiol) by Bayer Inc. | Disclosed in part | 89 |
| A-2011-00429 | Information regarding the product Jamp-Citalopram, DIN 02313405 by JampPharma Corporation. | Disclosed in part | 84 |
| A-2011-00477 | Information regarding the product WeiderBcaa, NPN 80017612. | Disclosed in part | 19 |
| A-2011-00495 | All correspondence between Janssen-Ortho Inc. and Health Canada regarding Novo- methylphenidate ER-C. | Disclosed in part | 64 |
| A-2011-00530 | AERs for the product Tylenol. Report numbers: 000223285, 000223428, 000223777, 000224725, 000224788, 000225136, 000300498, 000304995, 000307744 and 000307912. | Disclosed in part | 22 |
| A-2011-00532 | AERs for the product Tylenol. Report numbers: 000310913, 000310914, 000310920, 000310924, 000310925, 000310928, 000310929, 000310935, 000311863 et 000313378. | Disclosed in part | 71 |
| A-2011-00550 | Document Ensuring the Authenticity of Electronic Prescriptions. | Disclosed in part | 94 |
| A-2011-00562 | All documentsregarding Pursuit Herbicide by BASF Canada Inc. | Disclosed in part | 276 |
| A-2011-00591 | Information about the payment that the manufacturers / importers are required to provide under clauses 21(1)(a), 21(1)(b) and 21(1)(c) of the Tobacco Reporting Regulations for every tobacco manufacturer and importer that reported that it paid a service to use a consumer tobacco product related-brand element. (Jan 1,2010 to Jun 30, 2011). | No records exist | 0 |
| A-2011-00623 | All emails written by Stephanie Priest regarding energy drinks. (Jan 1, 2011 to Aug 18, 2011). | Disclosed in part | 40 |
| A-2011-00704 | AER for the product Panto IV. Report number: 000368003. | Disclosed in part | 3 |
| A-2011-00708 | Information regarding the product Sandoz Felodipineby Sandoz Canada Inc. | Disclosed in part | 162 |
| A-2011-00712 | AERs for the product Betaseron. Report numbers: 000368055, 000368081, 000368082, 000368115, 000368117, 000368118, 000368121, 000368123, 000368677 and 000369998. | Disclosed in part | 66 |
| A-2011-00723 | All briefing materials prepared for the Minister or Deputy Minister on the Canadian Blood Services lifetime ban on gay men donating blood. (Jan 1, 2011 to Sep 20, 2011). | All disclosed | 8 |
| A-2011-00729 | All proposals, contracts, the contractor selection scores, and final feasibility report with respect to the Request for Proposal number 000128834. | Disclosed in part | 114 |
| A-2011-00734 | All approvability (patent hold) letters sent by Health Canada for all generic companies who have received a notice of compliance regarding desloratadine. | Disclosed in part | 5 |
| A-2011-00736 | All approvability (patent hold) letters sent by Health Canada for all generic companies who have received a notice of compliance regarding valacyclovir. | Disclosed in part | 10 |
| A-2011-00749 | Information regarding the product Fermalac Vaginal, NPN 00232599 by InstitutRosell Inc. | Disclosed in part | 78 |
| A-2011-00783 | Information regarding the product Thayers Slippery Elm Lozenges, NPN 80023845. | Disclosed in part | 12 |
| A-2011-00819 | AER for the product Ultiva. Report number: 000361211. | All disclosed | 3 |
| A-2011-00832 | Information regarding the product XYLOCAINE 2% JELLY, DIN 00385484 by AstraZeneca Canada Inc | Disclosed in part | 64 |
| A-2011-00894 | Information regarding the product FASTIN CAP 30 mg, DIN 01916831 by Smithkline Beecham Pharma. | Disclosed in part | 9 |
| A-2011-00896 | Product Monograph for the product Heparin Sodium. | All disclosed | 42 |
| A-2011-00907 | All agendas, minutes and supporting documents/reports of the Toy Committee. (Mar1, 2011 to Oct 5, 2011). | Disclosed in part | 112 |
| A-2011-00921 | List of documents in MECS. (Oct 1, 2011 to Oct 31, 2011) | Disclosed in part | 4 |
| A-2011-00924 | Statistics on 'medical device user error' reported. (Jan 1, 2006 to Nov 2, 2011). | Disclosed in part | 8 |
| A-2011-00937 | Number of SAP releases for the following drug for the month of October 2011: Afatinib. | All disclosed | 1 |
| A-2011-00946 | All callups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of October 2011. | Disclosed in part | 86 |
| A-2011-00947 | All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of October 2011. | Disclosed in part | 1 |
| A-2011-00948 | Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during October 2011. | All disclosed | 1 |
| A-2011-00956 | Information regarding the Number of people in Chilliwack, Kent, Harrison Hot Springs, and Abbotsford licensed to grow Medical Marijuana. | All disclosed | 1 |
| A-2011-00963 | Health Canada's Risk Assessment Report on p-synephrine. | All disclosed | 47 |
| A-2011-00965 | Documents regarding warning letters to Mohawk Trading also known as CigarChief over signs on Highway 49 in Ontario. | Disclosed in part | 76 |
| A-2011-00968 | AERs for the product Strattera. Report numbers: 000366186 and 000367896. | Disclosed in part | 6 |
| A-2011-00970 | AER for the product Prozac. Report number: 000366154. | Disclosed in part | 7 |
| A-2011-00976 | A listing of the Access to Information requests submitted to Health Canada. (Oct 1, 2011 to Oct 31, 2011). | Disclosed in part | 10 |
| A-2011-00978 | AERs for the product Synthroid. Report numbers: 000360233 and 000363411. | Disclosed in part | 3 |
| A-2011-01014 | Previously released request A-2006-01398: Information regarding research documents and statistics relating to reducing the number of tobacco consumers/consumption. | Disclosed in part | 74 |
| A-2011-01015 | Previously released request A-2007-00641: Information regarding correspondence between Health Canada and non-governmental organizations and any anti-smoking groups. | Disclosed in part | 1 |
| A-2011-01026 | AERs for the product Biaxin. Report numbers: 000362839 and 000364934. | Disclosed in part | 4 |
| A-2011-01028 | Previously released request A-2007-00410: Information regarding briefing materials relating to links between aboriginal and illegal tobacco sales. | Disclosed in part | 99 |
| A-2011-01029 | Previously released request A-2007-00448: Information regarding tobacco product brands produced and sold on Indian Reserves. | Disclosed in part | 570 |
| A-2011-01030 | Previously released request A-2007-00548: Information regarding Federal Tobacco Control Strategy for First Nations and Inuit. | Disclosed in part | 30 |
| A-2011-01031 | Previously released request A-2007-00747: Information regarding cigarette smuggling, tobacco taxation and/or native tobacco manufacturing that appears to have been created in or about the 2004-2007 period. | Disclosed in part | 31 |
| A-2011-01033 | Previously released request A-2007-00781: Information regarding Tobacco. | Disclosed in part | 8,134 |
| A-2011-01042 | Number of SAP releases for the following drug for the year 2011: Brentuximab. | All disclosed | 1 |
| A-2011-01047 | Number of SAP releases for the following drug for the year 2010: Bendamustine. | All disclosed | 1 |
| A-2011-01049 | All documents and data in the Consumer Product Safety Directorate's possession pertaining to the testing and/or safety of Graco brand 'TurboBooster' child booster seats. (Jan 1, 2000 to Nov 14, 2011). | Disclosed in part | 4 |
| A-2011-01052 | AERs for the product AVELOX. Report numbers: 000370048, 000370669 and 000371331. | Disclosed in part | 4 |
| A-2011-01053 | AER for the product Cipro. Report number: 000370305. | Disclosed in part | 2 |
| A-2011-01054 | AERs for the product Gadovist. Report numbers: 000371837 and 000372992. | Disclosed in part | 2 |
| A-2011-01055 | AERs for the product Yasmin. Report numbers: 000370541, 000370583, 000370626, 000370675, 000370797, 000370926, 000371528, 000371651, 000371672 and 000372106. | Disclosed in part | 15 |
| A-2011-01056 | AERs for the product Yaz. Report numbers: 000370474, 000370673, 000371671 and 000371784. | Disclosed in part | 9 |
| A-2011-01057 | AERs for the product Xarelto. Report numbers: 000370910, 000371674 and 000372783. | Disclosed in part | 5 |
| A-2011-01077 | Electronic document showing all drinking water advisories currently in effect on First Nations communities across Canada. | All disclosed | 12 |
| A-2011-01082 | AERs for the product Humira. Report numbers: 000362764 and 000365182. | Disclosed in part | 2 |
| A-2011-01088 | Number of SAP releases for the following drug for the month of November 2011: Treanda. | All disclosed | 1 |
| A-2011-01089 | Number of SAP releases for the following drug for the month of November 2011: Targretin. | No records exist | 0 |
| A-2011-01091 | Number of SAP releases for the following drug for the month of November 2011: Dacogen. | All disclosed | 1 |
| A-2011-01093 | Number of SAP releases for the following drug for the month of November 2011: Carfilzomib. | No records exist | 0 |
| A-2011-01094 | Number of SAP releases for the following drug for the month of November 2011: Folotyn. | No records exist | 0 |
| A-2011-01096 | Number of SAP releases for the following drug for the month of November 2011: Zolinza. | No records exist | 0 |
| A-2011-01097 | Number of SAP releases for the following drug for the month of November 2011: Afatinib. | No records exist | 0 |
| A-2011-01099 | Number of SAP releases for the following drug for the month of November 2011: Prochymal. | No records exist | 0 |
| A-2011-01101 | Number of SAP releases for the following drug for the month of November 2011: Halaven. | All disclosed | 1 |
| A-2011-01102 | Number of SAP releases for the following drug for the month of November 2011: Cabazitaxel. | No records exist | 0 |
| A-2011-01103 | Number of SAP releases for the following drug for the month of November 2011: Belinostat. | No records exist | 0 |
| A-2011-01105 | Number of SAP releases for the following drug for the month of November 2011: Campath. | No records exist | 0 |
| A-2011-01107 | Number of SAP releases for the following drug for the month of November 2011: Feraheme. | No records exist | 0 |
| A-2011-01109 | Number of SAP releases for the following drug for the month of November 2011: Bendamustine. | All disclosed | 1 |
| A-2011-01111 | Number of SAP releases for the following drug for the month of November 2011: Brentuximab. | All disclosed | 1 |
| A-2011-01112 | AER for the product Celexa. Report number: 000347577. | Disclosed in part | 2 |
| A-2011-01145 | Product Monograph for the product Alphagan, DIN 02236876. | Disclosed in part | 35 |
| A-2011-01150 | Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during November 2011. | All disclosed | 2 |
| A-2011-01167 | A listing of the Access to Information requests submitted to Health Canada. (Nov 1, 2011 to Nov 30, 2011). | Disclosed in part | 8 |
